<?xml version="1.0" encoding="UTF-8"?>
<p>Regarding the group having chronic inflammatory arthropathy and using bDMARDs, 94 (56%) subjects had a diagnosis of rheumatoid arthritis, and the most frequent class of immunobiological used was antitumor necrosis factor biologicals (69%) (
 <xref rid="tab1" ref-type="table">Table 1</xref>).
</p>
